Skip to content
2000
Volume 16, Issue 5
  • ISSN: 1573-4099
  • E-ISSN: 1875-6697

Abstract

Background: A series of new six thiazolyl-2-amine-based Schiff base derivatives (4a-4f) were synthesized by a sequential multistep reaction starting with Salicylaldehyde. Methods: All the Schiff base derivatives were screened in-vitro for their antibacterial activity against Mycobacterium tuberculosis (H37RV strain) ATCC No-27294. The synthesized compounds were characterized by FTIR, 1H-NMR, 13C-NMR and Mass spectrometry. Results: Among the compounds tested, 4c and 4f derivatives exhibited potent antitubercular activity against M. tuberculosis at MIC 6.25 μg/mL. Conclusion: We extended our study to explore the inhibition mechanism by conducting molecular docking analysis by using Schrodinger’s molecular modeling software. All the newly synthesized compounds were found to be in-silico AMES test non-toxic and non-carcinogens. The good Qikprop’s Absorption, Distribution, Metabolism and Excretion (ADMET) would definitely help the researchers in order to make more potent Anti-TB agents.

Loading

Article metrics loading...

/content/journals/cad/10.2174/1386207322666190722162100
2020-10-01
2025-04-15
Loading full text...

Full text loading...

/content/journals/cad/10.2174/1386207322666190722162100
Loading

  • Article Type:
    Research Article
Keyword(s): coumarin; heterocyclic; molecular docking; schiff bases; Thiazole; tuberculosis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test